Mounjaro Weight Loss Tablets: Are They Available in the UK?

Weight Loss

Written By Aliysha Parveen - updated 03/09/2026 02:00Reviewed By Sidhi Nathwani - 05/10/2026 05:30 Editorial Policy

There is no tablet form of Mounjaro available anywhere in the world currently - the medication is only available as an injection. It’s possible there may be Mounjaro (tirzepatide) tablets in the future, but there’s no clear timeline for this currently. However, alternative GLP-1 tablets are already available to buy in the UK.

In this article, we’ll explore the possible development of Mounjaro tablets and discuss the currently available GLP-1 weight loss pills as alternatives.

Is there a Mounjaro pill?

No, there is not a Mounjaro pill on the market in any country at the moment. The active ingredient found in Mounjaro, tirzepatide, is only available in liquid form for injection right now.

Tirzepatide can’t currently be taken as a tablet as the drug is easily broken down in the stomach/gut and is poorly absorbed when taken in this way.

Injecting tirzepatide under the skin helps improve absorption and avoids the drug getting degraded by stomach acid/enzymes in the digestive system.

Is Eli Lilly developing a Mounjaro pill?

Eli Lilly, the pharmaceutical company that makes Mounjaro, hasn’t publicly announced that it’s developing a Mounjaro pill therefore as it stands we can not assume that there will be one available in the future.

However, the pharmaceutical company has been researching other weight loss drugs and has recently released an alternative weight loss tablet called Foundayo (active ingredient orforglipron).

Foundayo doesn’t contain the same ingredient as Mounjaro, tirzepatide, but it’s an alternative weight loss medication that can be taken as a tablet.

What's the difference between Orforglipron and Mounjaro?

Orforglipron and Mounjaro are both glucagon-like peptide 1 (GLP-1) medications, but Mounjaro also targets another hunger hormone and is injected while Foundayo is a single-action tablet.

Both medications come with similar side effects, with the most common including nausea, vomiting, diarrhoea, constipation, and/or stomach pain. More information on side effects can be found in the patient information leaflets for each medication, or in our individual guides to Mounjaro and Foundayo.

How they work

Both Mounjaro and orforglipron act similarly to the hunger-controlling hormone GLP-1, slowing down how fast the stomach empties therefore keeping you fuller for longer and quietening hunger cues. This makes it easier to eat less and lose weight.

However, Mounjaro also mimics another hunger hormone called glucose-dependent insulinotropic polypeptide (GIP), meaning it’s a dual-action medication.

Their results

These slight differences in how they work mean Mounjaro may help people to lose more weight, on average.

After 52 weeks, 87.8% of people taking the highest Mounjaro dose had lost at least 5% of their body weight compared to 77.1% of people on the highest Foundayo dose after 72 weeks.

How they’re taken

Mounjaro is taken as a weekly injection, given just under the skin, while Foundayo is taken as a daily tablet.

With both medications, you’ll start at a very low dose and increase it every 30 days (or longer) as you get used to it. The dose strengths vary between the two medications.

Learn more about the two medications and how they compare in our Foundayo vs Mounjaro comparison guide.

Are there any Mounjaro tablet alternatives available now?

Foundayo and Wegovy are the two GLP-1 weight loss pills that are currently available to buy in the UK.

Both belong to the same medication family, but there are differences in when/how they can be taken, the doses, and how effective each medication is for weight loss.

Learn more about the two medications and how they work in our GLP-1 tablets for weight loss guide.

Will there be a Mounjaro tablet in the future?

There may be a Mounjaro tablet in the future, but it’s not currently in development as far as we know.

As tablets tend to be more convenient to take than injections, it’s likely that more and more oral GLP-1 medications will continue to be developed and released. This may include oral Mounjaro, but we don’t know for sure.

We do know that several other weight loss tablets are currently undergoing clinical trials at different pharmaceutical companies.

We also know that Eli Lilly is testing another weight loss medication called retatrutide that targets three different hormones involved in hunger and metabolism. However, this will be taken as an injection rather than a tablet.

Should you wait for a Mounjaro tablet?

There’s no need to wait for Mounjaro tablets to be developed as lots of alternative weight loss tablets are already available.

Drugs take a lot of time to be developed and come onto the market, so you could be waiting a long time for Mounjaro tablets. It’s better to opt for an alternative medication rather than delaying treatment that you could benefit from.

If you’re not sure whether to swap from Mounjaro injections to a GLP-1 tablet or you want to learn more about the alternative options to Mounjaro, Quick Meds can help. We’re a UK-based GPhC-regulated online pharmacy with a collective 40 years of experience as pharmacists.

Start your weight loss consultation with us for personalised medication advice. We can prescribe the most appropriate weight loss medication for you after we’ve reviewed your individual situation.